Mosaic ImmunoEngineering Inc (CPMV)

[papadedavid]

New 10Q filed again on time...nothing new. We could be getting news about the agreement with Artius...but eveybody knows what are we really expecting here...;O).

https://www.otcmarkets.com/filing/html?id=13684032&guid=9WpfUHVz5DcNlth

Patriot Scientific Corporation

Notes to Unaudited Condensed Consolidated Financial Statements



PDS is currently pursuing a litigation strategy, which includes the filing, on September 6, 2019, a petition for a writ of certiorari with the Supreme Court of the United States in regards to a decision by the United States Court of Appeals for the Federal Circuit, stemming from litigation in U.S. District Court against multiple companies alleged to be infringers of the MMP portfolio. We continue to believe that the significant investment in legal effort and costs incurred to date at PDS is necessary for the protection of our interests in the MMP portfolio and its future success, although to date it has generated mixed results.



On March 20, 2013, TPL filed a petition under Chapter 11 of the United States Bankruptcy Code. On March 5, 2018, TPL’s Motion for Entry of Final Decree Closing Chapter 11 was granted. In the event we are required to provide funding to PDS that is not reciprocated by TPL, our ownership percentage in PDS will increase and we will have a controlling financial interest in PDS, in which case, we will consolidate PDS in our consolidated financial statements.



On April 12, 2019, we entered into an agreement with Artius Bioconsulting LLC, (“Artius”), to evaluate the potential of establishing a company that develops a platform that could be implemented throughout the drug development process utilizing blockchain technologies. We are anticipating receiving shortly a feasibility report with its analysis. In the event the next steps in the development of a blockchain based business are undertaken, it is expected that funding from external sources will be required.